Bintang Mitra Semestaraya Tbk vs Merck Tbk. — how do they compare? Bintang Mitra Semestaraya Tbk trades at Rp300 (market cap 350.08B, 1.6K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 13.4K 24h volume). The key difference: Merck Tbk. is far larger — about 4.9× Bintang Mitra Semestaraya Tbk's market cap, and Merck Tbk. is more actively traded (13.4K versus 1.6K). Which is the better fit depends on your goals.
| BMSR | MERK | |
|---|---|---|
Market Cap | 350.08B | 1.7T |
Volume | 1.6K | 13.4K |
Lot | 16 | 134 |
Turnover | 481.6K | 51.3M |
Average Price | 301 | 3,828.51 |
Value | 481.6K | 51.3M |
Indicative Equilibrium Price | — | 3,850 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bintang Mitra Semestaraya Tbk (the Company) was established on November 16, 1989 based on Notarial Deed No. 240 of Mrs Siti Pertiwi Henny Shidki, S.H., which had been amended by Notarial Deed No. 246 dated May 31, 1991 by the same Notary regarding the change of name from PT Bintang Mahkota Semestaraya into PT Bintang Mitra Semestaraya. BMSR is a company that concentrate its business on investing its capital on property companies. It generally invest its capital through subsidiary companies and groups in developing commercial buildings, apartments and general housing.
Read more on BMSR →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →